CRIS Current Research Information System

ANDRISANO, VINCENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.892
AS - Asia 17.138
EU - Europa 13.459
AF - Africa 984
SA - Sud America 923
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 37
Totale 50.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.646
CN - Cina 4.733
SG - Singapore 4.408
VN - Vietnam 4.295
IT - Italia 3.259
GB - Regno Unito 3.107
DE - Germania 1.604
SE - Svezia 1.127
HK - Hong Kong 1.050
UA - Ucraina 964
IN - India 871
FR - Francia 811
RU - Federazione Russa 696
BR - Brasile 652
IE - Irlanda 415
KR - Corea 392
JP - Giappone 336
CI - Costa d'Avorio 325
NL - Olanda 260
BD - Bangladesh 253
ZA - Sudafrica 251
EE - Estonia 230
FI - Finlandia 184
TG - Togo 151
CA - Canada 146
SC - Seychelles 132
BG - Bulgaria 121
CH - Svizzera 120
AR - Argentina 113
ES - Italia 107
ID - Indonesia 97
PH - Filippine 89
TR - Turchia 87
PL - Polonia 86
TH - Thailandia 72
JO - Giordania 69
MX - Messico 68
TW - Taiwan 64
BE - Belgio 60
HR - Croazia 55
IQ - Iraq 51
PK - Pakistan 50
IR - Iran 49
EC - Ecuador 44
GR - Grecia 44
CZ - Repubblica Ceca 42
EU - Europa 38
AT - Austria 36
SA - Arabia Saudita 36
CL - Cile 32
AU - Australia 31
CO - Colombia 31
RO - Romania 31
NG - Nigeria 23
DK - Danimarca 21
MY - Malesia 21
DZ - Algeria 19
LB - Libano 19
MA - Marocco 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
EG - Egitto 15
VE - Venezuela 14
PT - Portogallo 13
TN - Tunisia 13
PY - Paraguay 12
KE - Kenya 11
LT - Lituania 10
HU - Ungheria 9
IL - Israele 9
SI - Slovenia 9
AZ - Azerbaigian 8
BO - Bolivia 8
HN - Honduras 8
MD - Moldavia 8
NP - Nepal 8
PE - Perù 8
GT - Guatemala 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SM - San Marino 7
LK - Sri Lanka 6
UY - Uruguay 6
AL - Albania 5
AO - Angola 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
ET - Etiopia 4
JM - Giamaica 4
BH - Bahrain 3
CM - Camerun 3
CR - Costa Rica 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
BN - Brunei Darussalam 2
CG - Congo 2
KW - Kuwait 2
KZ - Kazakistan 2
Totale 50.432
Salva come PNG Salva come JPEG
Città #
Singapore 3.024
Southend 2.620
Ashburn 1.965
Fairfield 1.324
Chandler 1.176
Ho Chi Minh City 978
Hong Kong 973
San Jose 966
Santa Clara 936
Hanoi 808
Hefei 802
Houston 782
Wilmington 747
Bologna 741
Jacksonville 673
Woodbridge 625
Dong Ket 619
Princeton 613
Seattle 565
Ann Arbor 503
Beijing 502
Cambridge 454
Boardman 416
Dublin 414
Abidjan 325
Seoul 302
Nanjing 296
Lauterbourg 288
Tokyo 288
Council Bluffs 287
Los Angeles 276
Westminster 268
Padova 264
Berlin 226
Dallas 222
New York 217
Milan 209
Jinan 197
Buffalo 162
Shenyang 152
Helsinki 151
Lomé 151
Medford 135
Da Nang 133
Saint Petersburg 130
Guangzhou 128
Changsha 118
Haiphong 116
Sofia 115
Turin 115
Mülheim 112
Redondo Beach 99
Falls Church 96
Tianjin 95
Nanchang 94
Rome 92
Hebei 90
Bengaluru 87
San Diego 84
Shanghai 84
Mahé 83
Cesena 82
Frankfurt am Main 79
Munich 77
Zhengzhou 76
Bern 74
São Paulo 74
Amman 69
Hải Dương 65
Dearborn 62
Jiaxing 61
Redmond 59
Bremen 57
Biên Hòa 55
Des Moines 55
Hangzhou 55
Phoenix 54
Rimini 52
Chicago 50
Haikou 50
Brussels 49
San Francisco 49
Carpi 48
Orem 48
Jakarta 47
Taiyuan 45
Hyderabad 44
Norwalk 44
Verona 43
Brooklyn 42
Warsaw 42
Forlì 41
London 41
Redwood City 40
Can Tho 39
Cardiff 39
Taizhou 39
Florence 37
Olalla 37
Paris 36
Totale 31.569
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 541
A small molecule targeting the multifactorial nature of Alzheimer's disease 533
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 431
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 426
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 424
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 402
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 339
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 338
Analisi farmaceutica: metodi di riconoscimento e di separazione 328
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 312
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 297
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 295
Advanced analytical methodologies in Alzheimer's disease drug discovery 292
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 287
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 285
Analisi farmaceutica. Metodi di riconoscimento e di separazione 274
Influence of high-pressure homogenization treatments combined with lysozyme activated packaging on microbiological and technological quality of vegetable smoothie during shelf life 269
INFLUENCE OF AN INNOVATIVE, BIODEGRADABLE MULTILAYER ACTIVE PACKAGING ON “PESTO” SAUCE CHARACTERISTICS DURING STORAGE 261
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: structure-based design, synthesis, and biological evaluation 260
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 252
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 252
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 247
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 237
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 232
Influence of an innovative, biodegradable active packaging on the quality of sunflower oil and “pesto” sauce during storage 227
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 224
null 222
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 218
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6 218
Rational Approach to discover multipotent anti-Alzheimer drugs 217
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer’s Disease 217
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 214
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 211
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 209
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 208
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues 206
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 206
Development of a new bio-compostable thin film for food packaging with in-line plasma treatment 204
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 202
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 202
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 201
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 200
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 200
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 199
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 197
Determination of levamisole and tetramisole in seized cocaine samples by enantioselective high-performance liquid chromatography and circular dichroism detection 197
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 196
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 194
EcoPackLab: a new laboratory for the development of new food packaging with long shelf life 194
Comprehensive amino acids profiling of microalgae by gas chromatography-mass spectrometry analysis after pre-column derivatization 189
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 188
Determination of dextromethorphan and levomethorphan in seized heroin samples by enantioselective HPLC and electronic CD 186
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 186
AFM study of F-actin on chemically modified surfaces 185
Choosing the right chromatographic support in making a new acetylcholinesterase-micro-immobilised enzyme reactor for drug discovery. 184
Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease 184
Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action 183
Analytical characterization of fruits waste for their valorization as sources of bioactive compounds. 180
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease 180
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 179
Monolytic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies 177
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks 177
Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorge 176
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 176
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 176
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases 176
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease 176
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties 175
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimers Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography 175
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 174
AFM study of F-actin on chemically modified surfaces 174
Simultaneous micellar electrokinetic chromatography of adriblastina and tarabine PFS. Their application to some biological fluids. 173
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 173
Separation and quantitation of Fructose-6-phosphate and Fructose-1,6-diphosphate by LC-ESI-MS for the evaluation of Fructose-1,6-biphosphatase activity 172
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 171
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 171
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 171
GC-FID/MS method for the impurity profiling of synthetic d-allethrin. 170
Batch-wise covalent immobilisation of human acetylcholinesterase: kinetic and inhibition spectrophotometric studies 170
METODI ANALITICI INTEGRATI PER LA VALUTAZIONE DEL PROFILO D’AZIONE DI NUOVI FARMACI ANTI-ALZHEIMER. 170
Characterization of reversible and pseudo-irreversible Acetylcholinesterase inhibitors by means of immobilized enzyme reactor 170
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 170
Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets 170
Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. 170
Methotrexate determination in pharmaceuticals by enantioselective HPLC 169
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 169
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 169
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice 169
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates 168
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 168
CHOOSING THE RIGHT CHROMATOGRAPHIC SUPPORT FOR ENZYME-BASED MICRO-IMERS. 167
LC analysis of Oxytetracycline and Chlortetracycline: application for in vitro bio-equivalence study of veterinary medicines 166
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 165
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease 164
Phenolic and Antioxidant Characterization of Fruit By-Products for Their Nutraceuticals and Dietary Supplements Valorization under a Circular Bio-Economy Approach 163
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 163
Stereoselective analysis of allethrin by two dimensional achiral/chiral HPLC with UV/circular dichroism detection 162
Design, Synthesis and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease Modifying Agents for Alzheimer's Disease 162
Human recombinant beta-secretase immobilized enzyme reactor for fast hits’ selection and characterization from a virtual screening library 162
DEVELOPMENT AND CHARACTERIZATION OF A PACKED AChE-micro-IMER FOR DRUG DISCOVERY IN ALZHEIMER’S DISEASE 161
Totale 21.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.103 0 0 0 0 0 0 0 0 0 0 0 1.103
2021/20225.246 495 188 279 319 456 339 130 385 278 405 1.032 940
2022/20235.517 588 736 308 723 376 391 143 348 910 230 466 298
2023/20242.500 123 295 174 205 190 367 270 403 72 123 157 121
2024/20256.861 325 1.038 712 466 1.351 357 498 275 96 328 292 1.123
2025/202617.106 1.453 1.937 1.648 1.376 1.878 1.018 2.138 484 2.746 1.005 722 701
Totale 51.375